Enabling GMP Production of sgRNA for CRISPR-Based Cell and Gene Therapies

Описание к видео Enabling GMP Production of sgRNA for CRISPR-Based Cell and Gene Therapies

In this webinar, learn how to expedite your CRISPR-based research and cell therapy development toward clinical application. Kevin Holden, Head of Science at Synthego, will discuss: choosing the optimal sgRNA quality at each stage of your research, emerging trends and best practices for advancing toward clinical development, and navigating regulatory guidelines and avoiding potential obstacles.

Комментарии

Информация по комментариям в разработке

Похожие видео